This second update follows the recent NHS England decision on the commissioning and provision of pre-exposure prophylaxis (PrEP) for HIV prevention in which they declined to recommend a full roll-out of PrEP but offered £2 million for a small pilot implementation project.
17 hours ago | BHIVA / BASHH
Last week, the working draft for 2016 UN Political Declaration on HIV/AIDS was released with only a few days for comments. Called the Zero draft, like previous statements produced every five years, it is a list of observations, comments and goals. But using the UN Statement as a platform of human rights has become disconnected from the scientific and medical advances in HIV over the last five years. The bulk of the draft document could have been written at any time during the epidemic, certainly most of it could have been written in 2011. There is only one reference to dramatic changes in the WHO 2015 guidelines and only two references to PrEP.
28 April 2016 | i-Base
Pre-exposure prophylaxis (PrEP), the daily medication that prevents HIV infections, is efficacious and has real potential to help global and local efforts to reach prevention targets in Asia and the Pacific, according to the meeting report of “PrEPARING ASIA”, the region’s first and biggest, as well as the world’s first community-led, consultation on the rolling out of the medication. The report calls for PrEP to be included in national HIV prevention strategies, particularly for men who have sex with men (MSM) in Asia and the Pacific.
28 April 2016 | APCOM
A groundbreaking new drug tipped to stop the spread of HIV within just a few years will be available to more than 2,000 Queensland men under a $6 million trial program. Pressure had been mounting on the Queensland Government to expand its trial previously offered to just 50 men, after the New South Wales Government upped their program to include 3,700 men and Victoria offered 2,600 men the daily dosage pill.
26 April 2016 | ABC Online
The model suggested that over 20 years, enrolling a quarter of HIV uninfected injection drug users in a PrEP + screening + ART program would be the optimal approach for reducing HIV infection. However, at current drug prices this approach would cost the U.S. an additional $44 billion, which is equivalent to annually spending 10 percent of the current federal budget for domestic HIV/AIDS on PrEP for people who inject drugs.
26 April 2016 | Medical Xpress
Around the world, people have to jump through hoops, and sometimes break laws, just to get it.
23 April 2016 | Vocativ
Getting PrEP into the hands of young people at high risk for HIV infection is a priority that experts are now discussing. A recent webinar and Q&A session hosted by HIVE brought together PrEP providers from across the country to talk about some of these issues and share successes and challenges.
22 April 2016 | BETA blog
The City of West Hollywood is launching a comprehensive public-awareness campaign to inform the community about Pre-Exposure Prophylaxis, known as "PrEP." The campaign includes outdoor media advertising and targeted printed information with details about obtaining a PrEP prescription and about healthcare services available locally that contribute to helping prevent the spread of HIV.
21 April 2016 | City of West Hollywood
Ethics panels may be hindering HIV prevention efforts by requiring gay and bisexual adolescents to get parental consent before taking part in research, experts suggest.
21 April 2016 | Reuters
There have been major developments in both treatment and prevention of HIV/AIDS in the U.S. in recent years and one of the most promising ones is Pre-Exposure Prophylaxis or PrEP. However, as the persistently unacceptable high rates of new HIV infections underscore, PrEP and other biomedical interventions tools are not being applied effectively in Black communities. While new HIV diagnoses in the U.S. as a whole fell 19 percent between 2005 and 2014, new cases among Black gay and bisexual men, for example, increased by 87 percent.
19 April 2016 | PR Newswire